3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vomiting
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Postoperative Nausea and Vomiting
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Gynecologic Cancer
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma in Situ
1
Carcinoma
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Rituximab
16
zanubrutinib
12
ibrutinib
9
venetoclax
8
Cyclophosphamide
8
pirtobrutinib
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Sirolimus
5
Mycophenolic Acid
5
Bendamustine Hydrochloride
5
acalabrutinib
4
Peripheral Blood Stem Cell Transplantation
4
Dexamethasone
4
ixazomib
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Cyclosporine
3
Bortezomib
3
Biopsy
3
fludarabine
2
carfilzomib
2
Tacrolimus
2
Prednisone
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Ondansetron
×
1 year
×
Clear all
No trials found.